AN

ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş.

Designs, develops, and manufactures molecular diagnostic solutions and instruments.

ANGEN | IS

Overview

Corporate Details

ISIN(s):
TREANGN00010 (+1 more)
LEI:
789000SFK2PSN72IVM96
Country:
Türkiye
Address:
İSTANBUL PLAZA KASAP İSMAİL SOK.NO.10/22-23, 34722 ISTANBUL

Description

Anatolia Geneworks is a biotechnology company that designs, develops, and manufactures molecular diagnostic solutions. The company's main expertise lies in producing Real-Time Polymerase Chain Reaction (Real-Time PCR) kits, nucleic acid extraction kits, and automated instruments. Its product portfolio includes the Bosphore line of Real-Time PCR kits for detecting pathogens related to conditions like sepsis, gastroenteritis, and hepatitis. It also offers the UNIO family of automated systems for nucleic acid isolation and PCR setup, providing integrated workflow solutions for laboratories in healthcare and genetic testing.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-07-31 10:49
Yönetim Kurulu Üyelerinin Seçimi ve Görev Dağılımı Hk.
Turkish HTML 18.2 KB
2025-07-30 14:01
Kayıtlı Sermaye Tavanı İşlemlerine İlişkin Genel Kurul Onayı Hk.
Turkish PDF 1.2 MB
2025-07-30 14:01
Kayıtlı Sermaye Tavanı İşlemlerine İlişkin Genel Kurul Onayı Hk.
Turkish HTML 7.2 KB
2025-07-30 13:59
2024 Yılı Olağan Genel Kurul Toplantısında Kar Dağıtılmamasına İlişkin Kararın …
Turkish PDF 247.0 KB
2025-07-30 13:59
2024 Yılı Olağan Genel Kurul Toplantısında Kar Dağıtılmamasına İlişkin Kararın …
English HTML 29.6 KB
2025-07-30 13:57
2024 Yılı Olağan Genel Kurul Toplantısı Sonucu
Turkish PDF 1.2 MB
2025-07-30 13:57
2024 Yılı Olağan Genel Kurul Toplantısı Sonucu
Turkish PDF 1.2 MB
2025-07-30 13:57
2024 Yılı Olağan Genel Kurul Toplantısı Sonucu
Turkish PDF 308.0 KB
2025-07-30 13:57
2024 Yılı Olağan Genel Kurul Toplantısı Sonucu
Turkish PDF 142.3 KB
2025-07-30 13:57
2024 Yılı Olağan Genel Kurul Toplantısı Sonucu
Turkish PDF 1.5 MB
2025-07-30 13:57
2024 Yılı Olağan Genel Kurul Toplantısı Sonucu
Turkish HTML 18.4 KB
2025-06-25 17:12
2024 Yılı Olağan Genel Kurulu Hk
Turkish PDF 1.2 MB
2025-06-25 17:12
2024 Yılı Olağan Genel Kurulu Hk
Turkish PDF 1.2 MB
2025-06-25 17:12
2024 Yılı Olağan Genel Kurulu Hk
Turkish PDF 308.0 KB
2025-06-25 17:12
2024 Yılı Olağan Genel Kurulu Hk
Turkish HTML 15.1 KB

Automate Your Workflow. Get a real-time feed of all ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Develops drugs for intractable diseases by regulating oxidative stress and CAFs.
South Korea
293780
Aptamer Sciences Inc Logo
Clinical-stage company developing aptamer-based therapeutics for oncology.
South Korea
291650
Aptorum Group Ltd Logo
Clinical-stage biopharma developing therapeutics for oncology and infectious diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Pharmaceutical company developing oral film medicines for CNS and allergic reactions.
United States of America
AQST
Arbutus Biopharma Corp Logo
Clinical-stage biopharma company developing a functional cure for chronic Hepatitis B.
United States of America
ABUS
Arcellx, Inc. Logo
A clinical-stage biotech company developing immunotherapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharmaceutical and nutraceutical products from marine membrane lipids.
Norway
ABS
ArcticZymes Technologies Logo
Develops and manufactures novel recombinant enzymes from Arctic marine organisms.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
A commercial-stage mRNA medicines company focused on rare and infectious diseases.
United States of America
ARCT
Arcus Biosciences, Inc. Logo
A clinical-stage biopharmaceutical company developing combination therapies for cancer.
United States of America
RCUS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.